Compass Therapeutics, Inc. (CMPX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 148.60M |
| Enterprise value | -6.25M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.95 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -8.92 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -62.37% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 3.0100 |
| 52-week low 3 | 0.7650 |
| 50-day moving average 3 | 1.1804 |
| 200-day moving average 3 | 1.5660 |
Share statistics
| Avg vol (3-month) 3 | 341.69k |
| Avg vol (10-day) 3 | 354.9k |
| Shares outstanding 5 | 137.59M |
| Implied shares outstanding 6 | 137.59M |
| Float 8 | 98.07M |
| % held by insiders 1 | 12.04% |
| % held by institutions 1 | 70.84% |
| Shares short (15 Jul 2024) 4 | 2.02M |
| Short ratio (15 Jul 2024) 4 | 4.04 |
| Short % of float (15 Jul 2024) 4 | 2.08% |
| Short % of shares outstanding (15 Jul 2024) 4 | 1.47% |
| Shares short (prior month 14 Jun 2024) 4 | 1.58M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -19.13% |
| Return on equity (ttm) | -27.35% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -52.76M |
| Net income avi to common (ttm) | -45.44M |
| Diluted EPS (ttm) | -0.3500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 156.26M |
| Total cash per share (mrq) | 1.14 |
| Total debt (mrq) | 1.41M |
| Total debt/equity (mrq) | 0.90% |
| Current ratio (mrq) | 40.74 |
| Book value per share (mrq) | 1.14 |
Cash flow statement
| Operating cash flow (ttm) | -42.28M |
| Levered free cash flow (ttm) | -26.01M |
© 2024 Yahoo. All rights reserved.